98 related articles for article (PubMed ID: 25814384)
1. MEF2D overexpression contributes to the progression of osteosarcoma.
Yu H; Sun H; Bai Y; Han J; Liu G; Liu Y; Zhang N
Gene; 2015 Jun; 563(2):130-5. PubMed ID: 25814384
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes.
Ma L; Liu J; Liu L; Duan G; Wang Q; Xu Y; Xia F; Shan J; Shen J; Yang Z; Bie P; Cui Y; Bian XW; Prieto J; Avila MA; Qian C
Cancer Res; 2014 Mar; 74(5):1452-62. PubMed ID: 24390737
[TBL] [Abstract][Full Text] [Related]
3. MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation.
Xu J; Yao Q; Hou Y; Xu M; Liu S; Yang L; Zhang L; Xu H
Biomed Pharmacother; 2013 Jun; 67(5):381-6. PubMed ID: 23601845
[TBL] [Abstract][Full Text] [Related]
4. MEF2D/Wnt/β-catenin pathway regulates the proliferation of gastric cancer cells and is regulated by microRNA-19.
Xu K; Zhao YC
Tumour Biol; 2016 Jul; 37(7):9059-69. PubMed ID: 26762410
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation.
Zhao W; Zhang D; Qin P; Zhang J; Cui X; Gao J; Wang J; Li J
Int J Biol Macromol; 2019 May; 128():566-573. PubMed ID: 30703420
[TBL] [Abstract][Full Text] [Related]
6. miR-218 suppresses cardiac myxoma proliferation by targeting myocyte enhancer factor 2D.
Cao Q; Dong P; Wang Y; Zhang J; Shi X; Wang Y
Oncol Rep; 2015 May; 33(5):2606-12. PubMed ID: 25812649
[TBL] [Abstract][Full Text] [Related]
7. miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.
Xu Z; Wang T
Biochem Biophys Res Commun; 2014 Jun; 449(2):190-5. PubMed ID: 24802407
[TBL] [Abstract][Full Text] [Related]
8. miR-218 suppressed the growth of lung carcinoma by reducing MEF2D expression.
Song L; Li D; Zhao Y; Gu Y; Zhao D; Li X; Bai X; Sun Y; Zhang X; Sun H; Wang Y; Peng L
Tumour Biol; 2016 Mar; 37(3):2891-900. PubMed ID: 26409449
[TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressing effects of miR451 in human osteosarcoma.
Xu H; Mei Q; Shi L; Lu J; Zhao J; Fu Q
Cell Biochem Biophys; 2014 May; 69(1):163-8. PubMed ID: 24218283
[TBL] [Abstract][Full Text] [Related]
10. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
11. MiR-1 Suppresses Proliferation of Osteosarcoma Cells by Up-regulating p21
Fujii R; Osaka E; Sato K; Tokuhashi Y
Cancer Genomics Proteomics; 2019; 16(1):71-79. PubMed ID: 30587501
[TBL] [Abstract][Full Text] [Related]
12. microRNA‑25 promotes osteosarcoma cell proliferation by targeting the cell‑cycle inhibitor p27.
Wang XH; Cai P; Wang MH; Wang Z
Mol Med Rep; 2014 Aug; 10(2):855-9. PubMed ID: 24859599
[TBL] [Abstract][Full Text] [Related]
13. Myocyte enhancer factor 2D promotes tumorigenicity in malignant glioma cells.
Zhao Y; Li Y; Ma Y; Wang S; Cheng J; Yang T; Sun Z; Kuang Y; Huang H; Fan K; Gu J
Tumour Biol; 2016 Jan; 37(1):601-10. PubMed ID: 26234765
[TBL] [Abstract][Full Text] [Related]
14. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
[TBL] [Abstract][Full Text] [Related]
15. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
16. The control operated by the cell cycle machinery on MEF2 stability contributes to the downregulation of CDKN1A and entry into S phase.
Di Giorgio E; Gagliostro E; Clocchiatti A; Brancolini C
Mol Cell Biol; 2015 May; 35(9):1633-47. PubMed ID: 25733682
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-135b promotes proliferation, invasion and migration of osteosarcoma cells by degrading myocardin.
Xu WG; Shang YL; Cong XR; Bian X; Yuan Z
Int J Oncol; 2014 Nov; 45(5):2024-32. PubMed ID: 25190111
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.
Ji F; Zhang H; Wang Y; Li M; Xu W; Kang Y; Wang Z; Wang Z; Cheng P; Tong D; Li C; Tang H
Bone; 2013 Sep; 56(1):220-6. PubMed ID: 23756231
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA SNHG6 promotes osteosarcoma cell proliferation through regulating p21 and KLF2.
Ruan J; Zheng L; Hu N; Guan G; Chen J; Zhou X; Li M
Arch Biochem Biophys; 2018 May; 646():128-136. PubMed ID: 29608878
[TBL] [Abstract][Full Text] [Related]
20. Pokemon promotes the invasiveness of hepatocellular carcinoma by enhancing MEF2D transcription.
Kong J; Liu X; Li X; Wu J; Wu N; Chen J; Fang F
Hepatol Int; 2016 May; 10(3):493-500. PubMed ID: 26797719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
